Cargando…
In vitro Antibacterial Activity of Doripenem against Gram-Negative Blood Isolates in a Korean Tertiary Care Center
BACKGROUND: Doripenem is the most recently introduced antimicrobial agent of the carbapenem class. It is a valuable therapeutic option in the context of increasing antimicrobial resistance to imipenem and meropenem among gram-negative bacilli (GNB) clinical isolates. However, clinicians are usually...
Autores principales: | Choi, Seong-Ho, Ahn, Mi Young, Chung, Jin-Won, Lee, Mi-Kyung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Infectious Diseases and Korean Society for Chemotherapy
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4607770/ https://www.ncbi.nlm.nih.gov/pubmed/26483991 http://dx.doi.org/10.3947/ic.2015.47.3.175 |
Ejemplares similares
-
Fingolimod Promotes Antibacterial Effect of Doripenem against Carbapenem-Resistant Escherichia coli
por: Jin, Hye-Won, et al.
Publicado: (2022) -
In vitro antibacterial activity of rifampicin in combination with imipenem, meropenem and doripenem against multidrug-resistant clinical isolates of Pseudomonas aeruginosa
por: Hu, Yi-Fan, et al.
Publicado: (2016) -
In Vitro Antibacterial Interaction of Doripenem and Amikacin against Multidrug-Resistant Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae Isolates
por: Loho, Tonny, et al.
Publicado: (2018) -
Utilization of the respiratory virus multiplex reverse transcription-polymerase chain reaction test for adult patients at a Korean tertiary care center
por: Ahn, Mi Young, et al.
Publicado: (2015) -
Association of doripenem resistance with OXA-type carbapenemases in Acinetobacter baumannii isolates
por: Terzi, Huseyin-Agah, et al.
Publicado: (2016)